Aims Nearly 60% of the world's population lives in Asia but little is known about the
characteristics and outcomes of Asian patients with heart failure with reduced ejection …

Background Data comparing outcomes in heart failure (HF) across Asia are limited. We
examined regional variation in mortality among patients with HF enrolled in the ASIAN‐HF …

Background: Little is known regarding the impact of socioeconomic factors on the use of
evidence-based therapies and outcomes in patients with heart failure with reduced ejection …

Aims Chronic heart failure with reduced ejection fraction (CHF-REF) remains a major public
health problem with high morbidity and mortality, but the data on current treatment status …

Background Heart failure (HF) is a global challenge, with lower-and middle-income
countries (LMICs) carrying a large share of the burden. Treatment for HF with reduced …

Background Recent studies have described the entity of heart failure with recovered ejection
fraction (HFrecEF), but population-specific studies remain lacking. The aim of this study was …

Background There are few data on heart failure (HF) patients from Africa, Asia, the Middle
East and South America. Methods INTER-CHF is a prospective study that enrolled HF …

BACKGROUND: Heart failure (HF) with preserved ejection fraction (EF) accounts for a
substantial proportion of cases of HF, and to date no treatments have clearly improved …

Background: Epidemiology of patients with worsening heart failure and reduced ejection
fraction (HFrEF) in the real-world setting is not well described. Objectives: The purpose of …

Background—Randomized trials have demonstrated the efficacy of several new therapies
for heart failure (HF) with reduced ejection fraction over the preceding 2 decades. This study …